Timbercreek Financial Announces 2025 First Quarter Results
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Timbercreek Financial (TSX: TF) (the 'Company') announced today its financial results for the three months ended March 31, 2025 ('Q1 2025').
Q1 2025 Highlights1
Strong top-line income and distributable income:
Net investment income of $28.6 million compared to $24.6 million in Q1 2024.
Net income and comprehensive income of $14.8 million (Q1 2024 – $14.4 million) or basic earnings per share of $0.18 (Q1 2024 – $0.17).
Distributable income of $15.4 million ($0.19 per share) compared with $15.8 million ($0.19 per share) in Q1 2024.
Declared a total of $14.3 million in dividends to shareholders, or $0.17 per share, reflecting a distributable income payout ratio of 92.8% (Q1 2024 – 90.6%).
The dividend remains well-covered and at the current trading price of $7.00 represent a 9.9% yield – a 7.3% premium over the 2-year Canadian bond yield (2.6% as at May 2, 2025).
The net mortgage investment portfolio increased by $101.6 million or 10.4% over the prior year and decreased modestly by $10.6 million to $1,079.2 million in Q1 2025.
The weighted average interest rate ("WAIR") on the portfolio remains resilient due to a high percentage of variable rate loans with protection of interest rate floors - as indicated by the Company's WAIR decreasing by 1.2% relative to a 2.3% drop in the Bank of Canada prime rate over the same period. At the end of Q1 2025, variable rate loans with rate floors represented 84.8% of the portfolio (Q1 2024 – 88.6%) and 87.8% of these variable rate loans with floors are currently at their floor rates.
While the Company continues to monitor developments closely with respect to tariffs and the potential impact to certain borrowers, its core asset class multi-family residential is expected to be well protected from any near-term implications and tends to perform well in periods of economic uncertainty.
In March, the Company completed the sale of a Quebec-based retirement asset. This transaction resulted in full recovery of real estate held for sale and a repayment of the Company's real estate collateral liability.
'It was a solid first quarter, with healthy income levels allowing us to build on our long-term track record of stable monthly dividends that deliver a premium yield to shareholders,' said Blair Tamblyn, CEO of Timbercreek Financial. 'The transaction pipeline remains robust, with some expected delays due to broader volatility in financial markets. Periods such as this underscore the resiliency of our strategy and our core asset classes, led by multi-residential. During the quarter, our team also continued to advance the remaining staged loans and expects material progress during 2025."
Quarterly ComparisonQ1 2025
Q1 2024
Q4 2024
Net Mortgage Investments1
$
1,079.2
$
977.5
$
1,089.8
Enhanced Return Portfolio Investments1
$
43.3
$
63.4
$
42.9
Real Estate Inventory
$
29.6
$
30.6
$
32.5
Real Estate held for sale, net of collateral liability
$
—
$
62.2
$
65.3
Joint Venture
$
18.1
$
—
$
—
Net Investment Income
$
28.6
$
24.6
$
27.9
Income from Operations
$
23.3
$
20.9
$
11.0
Net Income and comprehensive Income
$
14.8
$
14.4
$
2.4
Distributable income1
$
15.4
$
15.8
$
17.7
Dividends declared to Shareholders
$
14.3
$
14.3
$
14.3
Q1 2025
Q1 2024
Q4 2024
Dividends per share
$
0.17
$
0.17
$
0.17
Distributable income per share1
$
0.19
$
0.19
$
0.21
Earnings per share
$
0.18
$
0.17
$
0.03
Payout Ratio on Distributable Income1
92.8
%
90.6
%
80.8
%
Payout Ratio on Earnings per share
96.9
%
99.7
%
603.4
%
Q1 2025
Q1 2024
Q4 2024
Weighted Average Loan-to-Value
66.2
%
64.4
%
63.3
%
Weighted Average Remaining Term to Maturity
0.9 yr
0.8 yr
1.0 yr
First Mortgages
88.3
%
85.7
%
89.6
%
Cash-Flowing Properties
79.7
%
85.7
%
81.9
%
Multi-family residential
60.2
%
54.6
%
59.8
%
Floating Rate Loans with rate floors (at quarter end)
84.8
%
88.6
%
80.4
%
Weighted Average Interest Rate
For the quarter ended
8.7
%
9.9
%
8.9
%
Weighted Average Lender Fee
New and Renewed
0.9
%
0.8
%
1.0
%
New Net Mortgage Investment Only
1.1
%
0.9
%
1.2
%
Refer to non-IFRS measures section below for net mortgages, enhanced return portfolio investments and distributable income.
Quarterly Conference Call
Interested parties are invited to participate in a conference call with management on Tuesday, May 6, 2025 at 1:00 p.m. (ET) which will be followed by a question and answer period with analysts.
To join the Zoom Webinar:
If you are a Guest, please click the link below to join:
https://us02web.zoom.us/j/81298506156?pwd=mrzLmbreCBzYqZzfvu38bVEvub7Tpj.1
Webinar ID: 812 9850 6156Passcode: 1234
Or Telephone:
Dial (for higher quality, dial a number based on your current location):Canada: +1 780 666 0144, +1 204 272 7920, +1 438 809 7799, +1 587 328 1099, +1 647 374 4685, +1 647 558 0588, +1 778 907 2071 International numbers available: https://us02web.zoom.us/u/kbE03DvhIf
Speakers will receive a separate link to the Webinar.
The playback of the conference call will also be available on www.timbercreekfinancial.com following the call.
About the Company
Timbercreek Financial is a leading non-bank, commercial real estate lender providing shorter-duration, structured financing solutions to commercial real estate professionals. Our sophisticated, service-oriented approach allows us to meet the needs of borrowers, including faster execution and more flexible terms that are not typically provided by Canadian financial institutions. By employing thorough underwriting, active management and strong governance, we are able to meet these needs while generating strong risk-adjusted yields for investors. Further information is available on our website, www.timbercreekfinancial.com.
Non-IFRS Measures
The Company prepares and releases financial statements in accordance with IFRS. As a complement to results provided in accordance with IFRS, the Company discloses certain financial measures not recognized under IFRS and that do not have standard meanings prescribed by IFRS (collectively the "non-IFRS measures"). These non-IFRS measures are further described in Management's Discussion and Analysis ("MD&A") available on SEDAR+. Certain non-IFRS measures relating to net mortgages have been shown below. The Company has presented such non-IFRS measures because the Manager believes they are relevant measures of the Company's ability to earn and distribute cash dividends to shareholders and to evaluate its performance. The following non-IFRS financial measures should not be construed as alternatives to total net income and comprehensive income or cash flows from operating activities as determined in accordance with IFRS as indicators of the Company's performance.
Certain statements contained in this news release may contain projections and "forward looking statements" within the meaning of that phrase under Canadian securities laws. When used in this news release, the words "may", "would", "should", "could", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect", "objective" and similar expressions may be used to identify forward looking statements. By their nature, forward looking statements reflect the Company's current views, beliefs, assumptions and intentions and are subject to certain risks and uncertainties, known and unknown, including, without limitation, those risks disclosed in the Company's public filings. Many factors could cause actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by these forward looking statements. The Company does not intend to nor assumes any obligation to update these forward looking statements whether as a result of new information, plans, events or otherwise, unless required by law.
OPERATING RESULTS1
Three months ended
Year ended
March 31,
December 31,
NET INCOME AND COMPREHENSIVE INCOME
2025
2024
2024
Net investment income on financial assets measured at amortized cost
$
28,573
$
24,590
$
104,344
Fair value gain and other income on financial assets measured at FVTPL
102
337
1,041
Net rental income
266
474
1,544
Net income from joint venture
17
—
—
Gain on real estate properties and real estate held for sale collateral liability
—
—
1,500
Expenses:
Management fees
(2,903
)
(2,393
)
(10,548
)
Servicing fees
(134
)
(159
)
(555
)
Expected credit loss
(1,554
)
(912
)
(16,134
)
General and administrative
(1,027
)
(1,034
)
(3,340
)
Income from operations
$
23,340
$
20,903
$
77,852
Financing costs:
Financing cost on credit facility
(5,955
)
(4,285
)
(21,664
)
Financing cost on convertible debentures
(2,613
)
(2,250
)
(10,031
)
Net income and comprehensive income
$
14,772
$
14,368
$
46,157
Payout ratio on earnings per share
96.9
%
99.7
%
124.1
%
DISTRIBUTABLE INCOME
Net income and comprehensive income
$
14,772
$
14,368
$
46,157
Less: Amortization of lender fees
(2,779
)
(1,405
)
(6,588
)
Add: Lender fees received and receivable
1,339
1,179
7,610
Add: Amortization expense, credit facility
212
416
1,030
Add: Amortization expense, convertible debentures
294
243
1,110
Add: Accretion expense, convertible debentures
160
113
569
Add: Unrealized fair value (gain) loss on DSU
(97
)
153
38
Add: Unrealized (gain) loss on FVTPL
(36
)
(166
)
304
Add: Unrealized gain on real estate held for sale
—
—
(1,500
)
Add: Expected credit loss
1,554
912
16,134
Distributable income1
$
15,419
$
15,813
$
64,864
Payout ratio on distributable income1
92.8
%
90.6
%
88.3
%
PER SHARE INFORMATION
Dividends declared to shareholders
$
14,307
$
14,319
$
57,277
Weighted average common shares (in thousands)
82,981
83,010
83,010
Dividends per share
$
0.17
$
0.17
$
0.69
Earnings per share (basic)
$
0.18
$
0.17
$
0.56
Earnings per share (diluted)
$
0.18
$
0.17
$
0.56
Distributable income per share1
$
0.19
$
0.19
$
0.78
Refer to non-IFRS measures section.
Net mortgage investments(In thousands of Canadian dollars, except units, per unit amounts and where otherwise noted)
The Company's exposure to the financial returns is related to the net mortgage investments as mortgage syndication liabilities are non-recourse mortgages with periodic variance having no impact on Company's financial performance. Reconciliation of gross and net mortgage investments balance is as follows:
Net Mortgage Investments
March 31, 2025
December 31, 2024
Mortgage investments, excluding mortgage syndications
$
1,070,636
$
1,078,238
Mortgage syndications
613,964
427,263
Mortgage investments, including mortgage syndications
1,684,600
1,505,501
Mortgage syndication liabilities
(613,964
)
(427,263
)
1,070,636
1,078,238
Interest receivable
(15,699
)
(15,533
)
Unamortized lender fees
5,937
6,276
Expected credit loss
18,297
20,796
Net mortgage investments
$
1,079,171
$
1,089,777
Enhanced return portfolio
As at
March 31, 2025
December 31, 2024
Other loan investments, net of expected credit loss
$
31,332
$
30,912
Finance lease receivable, measured at amortized cost
6,020
6,020
Investment in participating debentures, measured at FVTPL
766
756
Joint venture investment in indirect real estate development
2,225
2,225
Investment in equity instrument, measured at FVTPL
3,000
3,000
Total enhanced return portfolio
$
43,343
$
42,913
Real estate held for sale, net of collateral liability
As at
March 31, 2025
December 31, 2024
Real estate held for sale
—
132,635
Real estate held for sale collateral liability
—
(67,312
)
Total real estate held for sale, net of collateral liability
$
—
$
65,323
SOURCE: Timbercreek Financial
For further information, please contact:
Timbercreek FinancialBlair Tamblyn, CEOTracy Johnston, CFO
416-923-9967www.timbercreekfinancial.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics ('Gyre') (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced that the first volunteer has been successfully dosed in a Phase 1 clinical trial evaluating F230, a novel endothelin A ('ETA') receptor antagonist, for the treatment of pulmonary arterial hypertension ('PAH').This milestone marks Gyre's entry into the PAH field, a rare, progressive, and high-mortality cardiovascular condition with limited treatment options. PAH is recognized in China's National Rare Disease Catalog, underscoring its significance in public health. According to Frost & Sullivan, China's PAH market was valued at $370 million in 2023 and is projected to grow to $480 million by 2031.F230, originally discovered by Eisai Co., Ltd. and exclusively licensed by GNI Group Ltd. to Gyre, is a fully synthetic small molecule designed to selectively block the ETA receptor. By targeting this pathway, F230 is designed to reduce pulmonary vascular remodeling and lower pulmonary pressure, key contributors to PAH Phase 1 trial is designed to evaluate safety, tolerability, and pharmacokinetics in healthy volunteers. The trial represents the latest expansion of Gyre's fibrosis-first strategy beyond the liver, leveraging a robust clinical development platform and commercial infrastructure in China.F230 joins Gyre's pipeline alongside lead candidate Hydronidone (F351), which met the primary endpoint in a pivotal Phase 3 trial for CHB-fibrosis. A New Drug Application ('NDA') submission to China's National Medical Products Administration ('NMPA') is planned for the third quarter of 2025, and a pre-IND meeting with the U.S. Food and Drug Administration is being planned for an expected Phase 2 trial in metabolic dysfunction-associated steatohepatitis ('MASH') Gyre TherapeuticsGyre Therapeutics is a biopharmaceutical company headquartered in San Diego, CA, primarily focused on the development and commercialization of Hydronidone for liver fibrosis, including MASH, in the U.S. Gyre's strategy builds on its experience in mechanistic studies using MASH rodent models and clinical studies in CHB-induced liver fibrosis. In the People's Republic of China, Gyre is advancing a broad pipeline through its indirect controlling interest in Gyre Pharmaceuticals, including therapeutic expansions of ETUARY, and development programs for F573, F528, and StatementsThis press release contains 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this press release, are forward-looking statements, including statements concerning the expectations regarding Gyre's research and development efforts and timing of expected clinical trials, including an NDA submission to the NMPA for F351, the expected clinical benefits of F230 and expectations regarding interactions with regulators. In some cases, you can identify forward-looking statements by terms such as 'may,' 'might,' 'will,' 'objective,' 'intend,' 'should,' 'could,' 'can,' 'would,' 'expect,' 'believe,' 'design,' 'estimate,' 'predict,' 'potential,' 'plan' or the negative of these terms, and similar expressions intended to identify forward-looking statements. These statements reflect our plans, estimates, and expectations, as of the date of this press release. These statements involve known and unknown risks, uncertainties and other factors that could cause our actual results to differ materially from the forward-looking statements expressed or implied in this press release. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation: Gyre's ability to execute on its clinical development strategies; positive results from a clinical trial may not necessarily be predictive of the results of future or ongoing clinical trials; the timing or likelihood of regulatory filings and approvals; competition from competing products; the impact of general economic, health, industrial or political conditions in the United States or internationally; the sufficiency of Gyre's capital resources and its ability to raise additional capital. Additional risks and factors are identified under 'Risk Factors' in Gyre's Annual Report on Form 10-K for the year ended December 31, 2024 filed on March 17, 2025 and in other filings Gyre may make with the SEC. Gyre expressly disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by Contact:David ZhangGyre in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
InStride Redefines Workforce Development Through Strategic Expansion
Empowering businesses with strategic education and skilling solutions that unlock career advancement and organizational impact LOS ANGELES, June 10, 2025 (GLOBE NEWSWIRE) -- InStride, a leading provider of strategic education and skilling solutions, today announced continued growth, accelerated by its new and transformative approach to workforce development. Recently named by TIME and Statista as one of the World's Top EdTech Companies of 2025, InStride has advanced its offerings to address critical talent challenges through education and skilling solutions designed to be career-aligned, industry-relevant, and tailored to its corporate partners' needs. In partnership with some of the most influential organizations in the Fortune 250, InStride provides nearly one million eligible employees access to over 2,500 education opportunities, helping prevent $73 million in student loan debt to date. 'Education benefits have come a long way from basic tuition reimbursement,' said Craig Maloney, CEO of InStride. 'We've reimagined them as strategic levers for HR teams to attract and retain talent, upskill their workforce, fill critical roles, and ensure their people are ready for what's next. Over the past six years, we've built programs that address such challenges and have seen the difference they can make for people and businesses alike.' Each of the following innovations was designed to make strategic education solutions more relevant, flexible, and effective—for the people using them and the companies supporting them. Award-winning, expanded offerings A broader, more flexible learning networkGone are the days of a one-size-fits-all workforce development. InStride's expanding portfolio of 2,500+ educational offerings with leading universities, such as Arizona State University, creates flexible pathways aligned with workforce demands. Formats include English-language programs, specialized healthcare certifications, and stackable credentials, all tailored to how people learn and grow. Career Education PathsInStride's award-winning Career Education Paths connect learning directly to career outcomes, increasing program completion rates. Honored by Fast Company and EdTech Breakthrough Awards, these structured paths are designed using Lightcast to map learning to 40+ specific roles across technology, healthcare, and corporate services. The result: higher engagement and a reliable pipeline of skilled talent. Dependent education benefitsInStride enables businesses to extend education benefits to employees' dependents. This allows employees at participating companies to use their benefits for spouses and children who gain access to career-aligned courses, certifications, and degrees, which enhances employee loyalty and retention as workers feel a deeper commitment to companies investing in their families. In turn, dependent benefits create a ripple effect beyond the workplace, helping to uplift communities by expanding access to education and opportunity for future generations. Supporting a skills-first approachInStride helps companies build talent strategies grounded in employee skills and capabilities. This includes helping companies identify the skills needed for key roles, map career paths, and uncover gaps between the skills employees have and the ones their businesses need. With that foundation in place, companies can make more informed hiring and promotion decisions—and use targeted learning programs to help employees build the skills to grow into critical roles. Pioneering, scalable, customizable solutions Hybrid clinical cohortsHealthcare systems can't rely solely on external hiring. InStride's hybrid clinical cohorts address staffing shortages in healthcare by combining online coursework with in-hospital training. With structured learning models to boost completion rates, they create pathways to in-demand roles like medical assistants, surgical technologists, and clinical lab specialists. This empowers employers to develop talent from within, which has proven to reduce staffing shortages and improve career mobility for existing employees. Industry-first franchise workforce education modelInStride's hub-and-spoke franchise education model allows franchisees to opt into and manage corporate education programs while customizing them for their workforce, providing centralized tracking and reporting tools for improved oversight. This balance between corporate structure and local flexibility helps franchise businesses retain and develop talent while maintaining a consistent workforce strategy. This approach has delivered impressive results, with over 50% of franchisees at one partner adopting the program in its first year and achieving a one-third higher retention rate for participating employees compared to non-participants. Custom solutions for accelerated capability buildingTo help businesses build specialized professional skill sets, InStride introduced Capability Accelerators, which provide custom academies tailored for specific roles including first-line managers, manufacturing and healthcare leaders; cohort-based learning with applied, real-world training featuring expert coaching and AI-enhanced tools; and university-backed content that blends academic insights with practical, job-relevant learning. 'We remain committed to building solutions that meet real workforce needs,' said Craig Maloney, CEO of InStride. He says of the company's future development: 'We're now investing more in AI that truly transforms individual careers and organizational success. We always start with our partners' business goals in mind—and by intelligently analyzing employee data like job roles, skills, and aspirations, we're better able to connect talent to the right education opportunities and personalized coaching support. That precision is what drives meaningful outcomes.'InStride solves corporate talent challenges with strategic education and skilling solutions. By breaking down barriers to learning, fostering career growth aligned with organizational goals, and simplifying program management, InStride delivers lasting impact. Partnering with forward-thinking companies like Labcorp, Adidas, and SSM Health, InStride drives meaningful social and business outcomes by providing access to life-changing education. Visit or follow InStride on LinkedIn for more information and up-to-date news. ContactSophia Puglisi, Communications Manager at InStride, 805-889-6273Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
Nordstrom Rack to Open New Location in Pompano Beach, FL
SEATTLE, June 10, 2025 /PRNewswire/ -- Seattle-based fashion retailer Nordstrom, Inc. announced plans to open a new Nordstrom Rack in Pompano Beach, FL in fall 2026. "We look forward to being a part of the Pompano Beach community and serving our customers with an amazing offering of great brands at great prices," said Gemma Lionello, President of Nordstrom Rack. "We're excited to grow our footprint in the Florida market and introduce new customers to the Nordstrom experience." Lionello added that in this location "customers will be able to take advantage of our convenient services such as online order pick up from both and and they can make returns easily." The 28,000 square foot store will be in Pompano Citi Centre, a popular shopping center that includes national tenants such as Burlington, Five Below, TJ Maxx, Ross Dress for Less, Chuck E. Cheese, and Amped Fitness. Pompano Citi Centre is owned and managed by Sterling Organization and is the largest critical mass of retail space in northeast Broward County and spanning almost 60 acres. Pompano Citi Centre is located at the intersection of Federal Highway and Copans Road in Pompano Beach, Florida. "We're thrilled to welcome Nordstrom Rack to Pompano Citi Centre," said Bob Dake, Principal at Sterling Organization. "Their presence adds tremendous value to our tenant mix and further strengthens our commitment to creating a dynamic, high-quality experience for the community." Nordstrom Rack is the off-price retail division of Nordstrom, Inc. and plays a critical role in the company's Closer to You strategy, which focuses on delivering customers a more convenient and interconnected experience across its stores and digital platforms. Nordstrom Rack offers customers up to 70 percent off on-trend apparel, accessories, beauty products, home decor and shoes from many of the top brands sold at Nordstrom stores as well as core services like online order pickup for and easy returns and alterations at select stores. Nordstrom Rack is the largest source of new customers to Nordstrom. This new location expands the company's physical footprint and economic impact in Florida. It currently operates six Nordstrom stores and 19 Nordstrom Rack stores in Florida, generating more than 2,700 jobs statewide. Nordstrom is committed to investing in the diverse communities where it operates. Over the past four years, Nordstrom, with its customers, has donated more than $2 million in support of its long-term partnership with Big Brothers Big Sisters of the United States. These proceeds support the recruitment, training and engagement of adult mentors and mentorship moments between Bigs and Littles, including preparing for an interview, learning to tie a tie and helping with homework. About Nordstrom At Nordstrom, Inc., we exist to help our customers feel good and look their best. Since starting as a shoe store in 1901, how to best serve customers has been at the center of every decision we make. This heritage of service is the foundation we're building on as we provide convenience and true connection for our customers. Our interconnected model enables us to serve customers when, where and how they want to shop – whether that's in-store at more than 350 Nordstrom, Nordstrom Local and Nordstrom Rack locations or digitally through our Nordstrom and Rack apps and websites. Through it all, we remain committed to leaving the world better than we found it. About Sterling OrganizationSterling Organization owns 77 properties across various funds in major markets throughout the United States, encompassing over 13 million square feet and exceeding $3 billion in value. Headquartered in West Palm Beach, FL, Sterling Organization operates with offices nationwide. MEDIA CONTACT: Manuela UscherNordstrom, Inc. NordstromPR@ View original content to download multimedia: SOURCE Nordstrom, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data